- 全部删除
- 您的购物车当前为空
Minretumomab(CC-49)是一种针对TAG-72(tumor-associated glycoprotein 72)的鼠源单克隆抗体,由B72.3抗体优化得到,可用于研究乳腺癌、结肠癌、肺癌和胰腺癌。
Minretumomab(CC-49)是一种针对TAG-72(tumor-associated glycoprotein 72)的鼠源单克隆抗体,由B72.3抗体优化得到,可用于研究乳腺癌、结肠癌、肺癌和胰腺癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,490 | In stock | |
5 mg | ¥ 6,470 | In stock | |
10 mg | ¥ 9,180 | In stock |
Minretumomab 相关产品
产品描述 | Minretumomab (CC-49) is a mouse monoclonal antibody targeting TAG-72 (tumour-associated glycoprotein 72), optimised from the B72.3 antibody, and can be used for research into breast cancer, colon cancer, lung cancer, and pancreatic cancer. |
体内活性 | 方法: |
别名 | 明瑞莫单抗 |
CAS No. | 195189-17-4 |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容